Understanding Key Drivers and Growth Opportunities in the Age-Related Macular Degeneration Market: Trends and Market Size Insights
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Major Innovations Are Driving the Accelerated Growth of the Age-Related Macular Degeneration Market?
The growth of the age-related macular degeneration (AMD) market is likely to be boosted by the increasing prevalence of AMD. AMD is a deteriorating eye disease that impacts the macula, a tiny area of the retina that maintains central vision. Treatments for AMD can help patients with retinal disorders reduce the severity of their conditions. In February 2023, Optimaxa, a UK-based expert in laser eye treatment, reported that AMD affected 196 million people worldwide and projects this figure to rise to 288 million by 2040, equivalent to 8.7% of the global population. This surge in AMD prevalence is contributing to the growth of the AMD market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10845&type=smp
#What is the Projected CAGR for the Age-Related Macular Degeneration Market Size from 2025 to 2034?
The market size of age-related macular degeneration has seen significant growth in the past few years. It is projected to increase from $9.96 billion in 2024 to around $10.7 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The rapid growth during the historical period is due to factors such as the rising elderly demographic, shifts in lifestyle and environmental conditions, genetic susceptibility, heightened awareness and early detection, and progress in diagnostic methods.
The market size for age-related macular degeneration is projected to witness a substantial surge in the coming years. It is predicted to escalate to “$14.38 billion by 2029, growing at a compound annual rate of 7.7%. The projected growth during the forecast period could be a result of advancements in genetic and biomarker research, breakthrough treatment modalities, remote monitoring through telemedicine, and improvements in patient awareness and education. The upcoming period will be marked by trends such as individualized medicinal approaches, advances in retinal imaging technologies, the advent of prolonged drug delivery systems, investigative therapeutic clinical trials, and partnerships in research and development.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10845
What Are the Most Significant Market Trends Transforming theAge-Related Macular Degeneration Market?
Leading businesses in the age-related macular degeneration (AMD) market are creating innovative solutions, such as bispecific antibodies, to decrease the frequency of treatments. Bispecific antibodies are engineered to bind to two distinct antigens at the same time. For instance, in May 2022, Chugai Pharmaceutical Co., Ltd., a Japanese pharmaceutical firm, introduced Vabysmo intravitreal injection 120 mg/mL. This is a bispecific antibody specially designed to treat eye disorders such as age-related macular degeneration (AMD) and diabetic macular edema (DME). This revolutionary treatment targets two crucial pathways simultaneously: angiopoietin-2 (Ang-2), which promotes abnormal blood vessel growth and inflammation, and Vascular Endothelial Growth Factor-A (VEGF-A), a principal driver in the development of new blood vessels that can result in vision loss. Vabysmo’s extended dosing schedule, allowing treatments every 16 weeks, significantly improves patient convenience and compliance. Its double-action strategy represents a significant advancement in ocular treatments, effectively meeting the pressing need for dependable therapies for retinal diseases.
What Are the Top Market Players Propelling the Growth of theAge-Related Macular Degeneration Industry?
Major companies operating in the age-related macular degeneration market include F. Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Pfizer Inc., Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Amgen Inc., Alimera Sciences Inc., Alkeus Pharmaceuticals Inc., AbbVie Inc., Outlook Therapeutics Inc., Biogen Inc., Samsung Bioepis Co. Ltd., Biocon Ltd., Bio-Thera Biopharmaceutical Co. Ltd., AstraZeneca plc, Acucela Inc., Ophthotech Corporation, Kodiak Sciences Inc., REGENXBIO Inc., Alkahest Inc., Opthea Limited, Apellis Pharmaceuticals Inc., Graybug Vision Inc., IVERIC bio Inc., Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., Tyrogenex Inc., Chengdu Kanghong Pharmaceutical Group Co. Ltd., I-Mab Biopharma Co. Ltd., pSivida Corp., Clearside Biomedical Inc., SciFluor Life Sciences LLC, Lineage Cell Therapeutics Inc.
Order Your Report Now For A Swift Delivery:
Which Primary Segments of the Age-Related Macular Degeneration Market Are Driving Growth and Industry Transformations?
The age-related macular degeneration market covered in this report is segmented –
1) By Type: Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)
2) By Drug: Eylea, Lucentis, Avastin, Other Products
3) By Route Of Administration: Intravenous, Intravitreal
4) By Distribution Channel: Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy
Subsegments:
1) By Wet Age-Related Macular Degeneration (AMD): Anti-VEGF Injections, Photodynamic Therapy, Laser Surgery
2) By Dry Age-Related Macular Degeneration (AMD): Nutritional Supplements, Low Vision Aids, Therapies For Geographic Atrophy
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=10845&type=smp
Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Age-Related Macular Degeneration Market?# Market?
North America was the largest region in the global age-related macular degeneration market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the age-related macular degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Gobal Age-Related Macular Degeneration Maret 2025, By The Business Research Company:
Newborn Eye Imaging Systems Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/newborn-eye-imaging-systems-global-market-report
Post-Traumatic Stress Disorder Therapeutics Global Market Report 2024
Bleeding Disorders Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
